The prognostic value of immediate post-TAVI hemodynamic evaluation is superior to aortography and transoesophageal echocardiography in predicting patient survival

Dékány, Gábor; Fontos, Géza; Satish, Sai; Szabó, Gergely; Pintér, Tünde; Piróth, Zsolt; Vértesaljai, Márton; Pál, Mátyás; Mandzák, Adrienn; Gulyás, Zalán; Gharehdaghi, Sara; Ferenci, Tamás; Andréka, Péter

doi:10.1016/j.ijcard.2020.12.058

Cited by 5 publications

(4 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our patient has no paravalvular leakage but revealed trivial transvalvular regurgitation and mild stenosis. Dekany et al reported the para-valvular regurgitation index as the most prognostic factor in post-TAVR patients who were followed up for 763 days (10). Accordingly, trivial transvalvular regurgitation does not significantly impact survival.…”

Section: Discussionmentioning

confidence: 99%

Valve In Valve Transaortic Valve Replacement (ViV-TAVR) in a Patient with Recurrent Pulmonary Edema: A Novel Procedure That Could Be Effective and Life-Saving in High-Risk Patients

Khani,

Namazi,

Alipour Parsa

et al. 2023

Int J Cardiovasc Pract

View full text Add to dashboard Cite

Background: Bio-prosthesis is the method of choice in managing aortic valve stenosis due to THE lesser probability of coagulation, even though higher valve replacement rates are undeniable. Valve-in-Valve Surgical Valve Replacement (ViV-SAVR) is shown to have lower rates of mortality than reoperation. We have reported a patient undergoing a ViV-SAVR procedure with exceptionally better results than in the literature. Case presentation: A 73-year-old Caucasian female was admitted with dyspnea and pulmonary edema with a bioprosthetic Mitroflow valve stented 10 years before admission. The echocardiography showed ejection fraction = 30%, left ventricular end-diastolic volume = 135 mL, LVEDV index = 72.9 mi∕m2, degenerated aortic valve with severe transvalvular aortic regurgitation, and mild aortic stenosis (mean gradient = 19 mmHg, peak gradient = 36 mmHg). The prosthetic valve was positioned on the previous Mitroflow bioprosthetic valve strut, followed by aortography. The patient was followed up for one month using transesophageal echocardiography, with no paravalvular leakage. Aortic transvalvular mean gradient of 16 mmHg and EOA of 1.3 cm2. Conclusion: ViV-SAVR is a method of treating aortic valve stenosis, which, if performed correctly, can enhance the survival and quality of life of the patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Valve In Valve Transaortic Valve Replacement (ViV-TAVR) in a Patient with Recurrent Pulmonary Edema: A Novel Procedure That Could Be Effective and Life-Saving in High-Risk Patients

Khani,

Namazi,

Alipour Parsa

et al. 2023

Int J Cardiovasc Pract

View full text Add to dashboard Cite

show abstract

“…Hemodynamics highly affect the treatment outcome of AVR-patients and are used as a marker for the intervention's success. [21][22][23] In addition to paravalvular leak, TPG is the main parameter to judge the success of the procedure and to estimate the patient's outcome. 21,22 Further, high WSS is known to promote the formation of aortic dilatation and aneurysms.…”

Section: Discussionmentioning

confidence: 99%

“…[21][22][23] In addition to paravalvular leak, TPG is the main parameter to judge the success of the procedure and to estimate the patient's outcome. 21,22 Further, high WSS is known to promote the formation of aortic dilatation and aneurysms. 24 It is recommended to perform echocardiography before discharge or within 30 days after valve implantation as well as 1 year after valve implantation to evaluate for hemodynamic function.…”

Section: Discussionmentioning

confidence: 99%

Comparison of hemodynamics in biological surgical aortic valve replacement and transcatheter aortic valve implantation: An in‐silico study

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Alternative access routes include subclavian, direct aortic, transapical and transcarotid. Access route selection will depend on operator preference, local experience and patient needs, with the latter remaining the only recommended way to improve outcomes in TAVI (Dekany et al, 2021). The replacement valve is deployed using a guidewire and specialised devices under fluoroscopy.…”

Section: Methodsmentioning

confidence: 99%

Transcatheter aortic valve implantation: an overview for nurses

Chamos

2022

British Journal of Cardiac Nursing

View full text Add to dashboard Cite

Transcatheter aortic valve implantation is non-inferior to surgical aortic valve replacement in managing severe aortic stenosis. It has been the treatment of choice for patients who would be unsuitable for surgical aortic valve replacement. Patient selection and workup involves a rigorous process to ensure a successful outcome, and patient monitoring is crucial during and after the procedure. Nurses play an important role throughout these stages, so developing their understanding of the different processes involved in each step of the procedure is imperative. This article provides an overview of transcatheter aortic valve implantation, from patient selection and workup to peri-procedure, highlighting considerations for nurses across these stages. It includes the most relevant and recent literature on transcatheter aortic valve implantation for evidence-based nursing care, such as the monitoring of complications, early mobilisation and next-day discharge. Furthermore, it includes discussion of future considerations and research on transcatheter aortic valve implantation.

show abstract

The prognostic value of immediate post-TAVI hemodynamic evaluation is superior to aortography and transoesophageal echocardiography in predicting patient survival

Cited by 5 publications

References 23 publications

Valve In Valve Transaortic Valve Replacement (ViV-TAVR) in a Patient with Recurrent Pulmonary Edema: A Novel Procedure That Could Be Effective and Life-Saving in High-Risk Patients

Valve In Valve Transaortic Valve Replacement (ViV-TAVR) in a Patient with Recurrent Pulmonary Edema: A Novel Procedure That Could Be Effective and Life-Saving in High-Risk Patients

Comparison of hemodynamics in biological surgical aortic valve replacement and transcatheter aortic valve implantation: An in‐silico study

Transcatheter aortic valve implantation: an overview for nurses

Contact Info

Product

Resources

About